Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT)

Journal of Controlled Release

Volumn 98, Issue 2, 2004, Pages 195-207

  Maruyama, Kazuo ^a   Ishida, Osamu ^a   Kasaoka, Satoshi ^a   Takizawa, Tomoko ^a   Utoguchi, Naoki ^a   Shinohara, Atsuko ^b   Chiba, Momoko ^b   Kobayashi, Hisao ^c   Eriguchi, Masazumi ^d   Yanagie, Hironobu ^d  

^a TEIKYO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKKYO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

AUC; BNCT; boron neutron capture therapy; BSH; CH; cholesterol; DDS; distearoylphosphatidylcholine; DSPC; DSPE; Immunoliposomes; mercaptoundecahydrododecaborate; Polyethyleneglycol; the area under the concentration time curve; Transferrin

Indexed keywords

ALCOHOLS; BONE; DRUG PRODUCTS; ORGANIC COMPOUNDS; TISSUE; TUMORS;

DRUG DELIVERY SYSTEMS; INTRACELLULAR TARGETING;

CELLS;

BOROCAPTATE; CHOLESTEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MACROGOL DERIVATIVE; MONOMETHYLPOLYETHYLENEGLYCOL SUCCINIMIDYLSUCCINATE; POLYETHYLENEGLYCOLBIS(SUCCINIMIDYLSUCCINATE); TRANSFERRIN; TRANSFERRIN RECEPTOR; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENCAPSULATION; ENDOCYTOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SOLID TUMOR; TUMOR GROWTH;

ANIMALS; AREA UNDER CURVE; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ISOTOPES; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS; NEUTRONS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SULFHYDRYL COMPOUNDS; SURVIVAL RATE; TISSUE DISTRIBUTION; TRANSFERRIN;

EID: 3242679701     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.04.018     Document Type: Article

References (32)

1. Hawthorne M.F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem., Int. Ed. Engl. 32:1993;950-984
2. Barth R.F., Soloway A.H., Fairchild R.G. Boron neutron capture therapy for cancer. Cancer Res. 50:1990;1061-1070
3. Barth R.F., Soloway A.H., Fairchild R.G., Brugger R.M. Boron neutron capture therapy for cancer. Cancer. 70:1992;2995-3007
4. Mahta S.C., Lu D.R. Targeted drug delivery for boron neutron capture therapy. Pharm. Res. 13:1996;344-351
5. Yanagie H., Tomita T., Kobayashi H., Fujii Y., Takashi T., Hasumi K., Nariuchi H., Sekiguchi M. Application of boronated anti-CEA immunoliposome to tumor cell growth inhibition in in vitro born capture therapy model. Br. J. Cancer. 63:1991;522-526
6. Yanagie H., Tomita T., Kobayashi H., Fujii Y., Nonaka Y., Hasumi K., Eriguchi M., Kobayashi T., Ono K. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br. J. Cancer. 75:1997;660-665
7. Maruyama K., Takizawa T., Yuda T., Kennel S., Huang L., Iwatsuru M. Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta. 1234:1995;74-80
8. Maruyama K., Takahashi N., Tagawa T., Nagaike K., Iwatsuru M. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into target solid tumors in vivo. FEBS Lett. 413:1997;177-180
9. Ishida O., Maruyama K., Tanahashi H., Iwatsuru M., Sasaki K., Eriguchi M., Yanagie H. Liposomes bearing polyethyleneglycol coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm. Res. 18:2001;1042-1048
10. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:1986;6387-6392
11. Ishida O., Maruyama K., Sasaki K., Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int. J. Pharm. 190:1999;49-56
12. Jain R.K., Gerlowski L.E. Extravascular transport in normal and tumor tissue. Crit. Rev. Oncol./Hematol. 5:1986;115-170
13. Dvorak H.F., Nagy J., Dvorak J. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133:1988;95-109
14. Wagner E., Curiel D., Cotton M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Deliv. Rev. 14:1994;113-135
15. Huebers H.A., Finch C.A. The physiology of transferrin and transferrin receptors. Physiol. Rev. 67:1987;520-582
16. Aisen P. The transferrin receptor and the release of iron from transferrin. Adv. Exp. Med. Biol. 365:1994;31-40
17. Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. U. S. A. 75:1978;4194-4198
18. Dautry-Varsat A., Ciechanover A., Lodish H. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 80:1983;2258-2262
19. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66:1925;375-400
20. Enoch H., Strittmatter P. Formation and properties of 1000-Å-diameter, single-bilayer phospholipid vesicles. Proc. Natl. Acad. Sci. U. S. A. 76:1979;145-149
21. Wu M.S., Robbins J., Bugianesi R., Ponpipom M., Shen T. Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim. Biophys. Acta. 674:1981;19-26
22. Maruyama K., Unezaki S., Takahashi N., Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta. 1149:1993;209-216
23. Shinohara A., Chiba M. Determination of boron in biological materials by high frequency plasma mass spectrometry. 12:2001;48-54
24. Unezaki S., Maruyama K., Husoda J., Nagae J., Koyanagi Y., Nakata M., Ishida O., Iwatsuru M., Tsuchiya S. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. 144:1996;11-17
25. Alam F., Soloway A., McGuire J., Carey W., Adams D. Dicesium N-succinimidyl 3-(undecahydroclosodo decaboranyldithio)propionate, a novel heterobifunctional boronating agent. J. Med. Chem. 28:1985;522-528
26. Hartman T., Carlsson J. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. Radiother. Oncol. 31:1994;61-75
27. 7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat. Res. 111:1987;14-25
28. Kobayashi T., Kanda K. Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy. Radiat. Res. 91:1982;77-94
29. Joel D., Fairchild R., Laissue J., Saraf S., Kalef-Ezra J., Slatkin D. Boron neutron capture therapy of intracerebral rat gliosarcomas. Proc. Natl. Acad. Sci. U. S. A. 87:1990;9808-9812
30. Ishida O., Maruyam K., Yanagie H., Eriguchi M., Iwatsuru M. Targeting chemotherapy to solid tumors with long-circulating thermosensitive liposomes and local hyperthermia. Jpn. J. Cancer Res. 91:2000;118-126
31. Katayama K., Takizawa T., Maruyama K., Iwatsuru M., Kono K. Fusogenic immunoliposomes modified by pH-sensitive PEG derivatives. Prog. Drug Deliv. Syst. 7:1998;29-38
32. Johnsson M., Bergstrand N., Edwards K. Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT). J. Liposome Res. 9:1999;53-79